Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
clinical trials
detroit blog main
detroit top stories
eli lilly
eptinezumab
erenumab
2
×
fda
fremanezumab
2
×
galcanezumab
indiana blog main
indiana top stories
life sciences
migraine research foundation
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
teva pharmaceutical
texas blog main
2
×
texas top stories
wisconsin blog main
wisconsin top stories
alder biopharmaceutical
alder biopharmaceuticals
What
approval
class
drug
fda
migraine
new
2
×
won
amgen
arguments
big
candidates
commercialized
companies
competitors
decades
developed
drugs
gets
head
make
medicines
meeting
neuro
nod
oral
pain
potential
preventive
starts
therapies
year
Language
Current search:
erenumab
×
" texas blog main "
×
new
×
fremanezumab
×
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines